Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,440.00
Bid: 1,431.00
Ask: 1,433.00
Change: 12.00 (0.84%)
Spread: 2.00 (0.14%)
Open: 1,439.00
High: 1,448.00
Low: 1,417.00
Prev. Close: 1,428.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

30 Sep 2022 13:39

RNS Number : 3949B
Indivior PLC
30 September 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Indivior PLC (the 'Company')

Result of General Meeting ('GM')

September 30, 2022

The Company announces the voting results of its GM, held earlier today at the offices of Freshfields Bruckhaus Deringer LLP, 100 Bishopsgate, London EC2P 2SR. All resolutions were duly passed by the requisite majority of shareholders by way of a poll.

Details of each resolution are set out in the shareholder circular including a Notice of Meeting (the Circular) circulated to shareholders on September 5, 2022.  The voting results, incorporating proxy votes lodged in advance of the GM, are set out below and will be made available on the Company's website at http://www.indivior.com/en/investors/shareholder-information .

Capitalised terms used but not defined in this announcement having the meaning given to them in the Circular.

 

RESOLUTION 

VOTES FOR

% 

VOTES AGAINST 

% 

VOTES TOTAL 

% of ISSUED ORDINARY SHARE CAPTIAL VOTED1 

VOTES WITHHELD2 

To adopt the new Articles of Association in connection with the Additional US Listing

508,605,977

99.96

178,400

0.04

508,784,377

73.81

34,455

To approve the Consolidation of the Company's issued capital in connection with the Additional US Listing pursuant to which every 5 ordinary shares will be consolidated into 1 ordinary share

508,516,860

99.95

258,968

0.05

508,775,828

73.81

39,004

 

Graham Hetherington, Chair, said:

We are pleased with the strong support received from shareholders that will allow us to move forward with an Additional US Listing of Indivior shares on a major US stock exchange. We believe the Additional US Listing will be beneficial in elevating Indivior's visibility and profile in its largest market, and will help attract a broader group of biopharma investors.

We anticipate that the Additional US Listing will become effective in the Spring of 2023 and the Group is diligently working on all requirements to meet this timing. Indivior will retain its premium listing on the London Stock Exchange and expects to continue to be a constituent of the FTSE 250 index.

Next steps and timetable

The expected timetable of principal events as set out in the Circular remains unchanged and is replicated below. The following dates are indicative only and are subject to change. If any of the dates set out in the timetable change, Indivior will give notice of this change by issuing an announcement through a Regulatory Information Service.

Event

Expected time/date

Consolidation Record Time

6.00 p.m. (London time) onOctober 7, 2022

Admission of New Ordinary Shares to listing on the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities and commencement of dealings in New Ordinary Shares

8.00 a.m. (London time) onOctober 10, 2022

Expected date CREST accounts are to be credited with New Ordinary Shares in uncertificated form

October 10, 2022

Expected date for dispatch of definitive certificates for New Ordinary Shares in certificated form

October 17, 2022

Expected date for payment (where applicable) of fractional entitlements for New Ordinary Shares

October 21, 2022

Expected time and date for admission and commencement of dealings in Indivior Shares on a major US stock exchange

By 8.00 a.m. (New York time) onMay 31, 2023

Expected date for issue of Indivior DIs to CREST participant accounts and crediting of CSN Facility accounts

On or around May 31, 2023

 

Notes:

 

1. As at the close of business on September 28, 2022, the total number of ordinary shares of US$0.10 eligible to be voted at the GM was 688,995,928. Therefore, the total voting rights in the Company as at that time was 688,995,928.

 

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'for' or 'against' a resolution.

A copy of the special business resolutions will be submitted to the National Storage Mechanism and will be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism in due course.

Computershare Investor Services PLC acted as scrutineer of the poll on all resolutions.

 

Contact: Kathryn Hudson

Company Secretary Tel: +44 (0)1753 423940 / cosec@indivior.com

Jason Thompson Vice President, Investor RelationsTel: +1-804-402-7123 / jason.thompson@indivior.com

Tulchan Communications Tel: +44 207-353-4200

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFZGFLZGNGZZM
Date   Source Headline
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20248:58 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNS1st Quarter Results
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20243:23 pmRNSHolding(s) in Company
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20242:53 pmRNSNotice of Results
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:02 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20242:07 pmRNSPublication of Notice of Annual General Meeting
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:00 pmRNSHolding(s) in Company
21st Mar 20242:30 pmRNSAppointment of Independent Non-Executive Director
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:14 pmRNSReplacement Director/PDMR Shareholding
18th Mar 20244:21 pmRNSDirector/PDMR Shareholding
18th Mar 20244:17 pmRNSDirector/PDMR Shareholding
18th Mar 20242:00 pmRNSDirector/PDMR Shareholding
18th Mar 202410:45 amRNSHolding(s) in Company
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20244:47 pmRNSDirector/PDMR Shareholding
15th Mar 20244:40 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20244:06 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.